Clinnova to Launch Precision Medicine Initiative Across Europe

Inaugurating a new initiative to foster AI-driven precision medicine via data federation, standardisation, and interoperability. Clinnova, an international project involving clinicians and researchers from Luxembourg, France, Germany and Switzerland, is being officially launched in Luxembourg on 27 April at a kick-off ceremony attended by the Ministers of Higher Education & Research and Health. The initiative aims to realise benefits of precision medicine for treatment decisions through data federation, standardisation, and interoperability. From left to right: Marc Berna (HRS), Jasmin Schulz (LIH), Marc Schiltz (FNR), Ulf Nehrbass (LIH), Claude Meisch (Minister of Higher Education & Research), Paulette Lenert (Minister of Health), Gregor Baertz (LIH), Simone Niclou (University of Luxembourg), Romain Nati (CHL) AI holds a huge potential in the healthcare field but its realisation faces challenges, notably in the data enabling context and the ability to build appropriate clinical studies. In this context, the Clinnova project, part of the National Centres of Excellence in Research (NCER) programme by the FNR, was conceived as a precision medicine initiative that tackles these challenges on three levels. To date there is no straightforward method available to decide what drug to prescribe for what patient. With new drugs coming on the markets in a steady flow, this leaves physicians and patients with a concrete problem: the wrong therapy may extend the disease burden while invoking unnecessary cost on the social system.